Hiroyuki Kuma
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Hiroyuki Kuma has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
Akira Tsukamoto
Advanced Research Laboratory, Hitachi, Ltd., Tokyo, Japan
3 shared publicationsKeiji Enpuku
Research Institute of Superconductor Science and Systems, Kyushu University, Fukuoka, Japan
3 shared publicationsKohji Yoshinaga
Department of Applied Chemistry, Kyushu Institute of Technology, Fukuoka, Japan
3 shared publicationsNaotaka Hamasaki
Department of Clinical Chemistry and Laboratory Medicine, Kyushu University School of Medicine, Fukuoka, Japan
3 shared publications- Naotaka Hamasaki
Department of Clinical Chemistry, Faculty of Pharmaceutical Sciences, Natagaki International University, Nagasaki, Japan
3 shared publications Yoshinori Sugiura
INOAC Corporation, Nagoya, Japan
3 shared publications
Latest Publications
- Open Access
- 29 January 2024
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 295, 67-74
The effects of dienogest and combined oral contraceptives on protein S-specific activity in endometriosis patients
- 29 January 2024
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 295, 67-74
Open AccessThe effects of dienogest and combined oral contraceptives on protein S-specific activity in endometriosis patients
- Open Access
- 27 November 2023
- Published by Elsevier in Practical Laboratory Medicine
- Vol. 37, e00345
A quantitative assay system for protein C activity, the regulator of blood coagulation, based on a chromogenic method mimicking the blood coagulation cascade
- 27 November 2023
- Published by Elsevier in Practical Laboratory Medicine
- Vol. 37, e00345
Open AccessA quantitative assay system for protein C activity, the regulator of blood coagulation, based on a chromogenic method mimicking the blood coagulation cascade
- 11 January 2022
- Published by Elsevier in Journal of Reproductive Immunology
- Vol. 150, 103476
The role of epidermal growth factor-like domain-related abnormalities, protein S Tokushima, and anti-protein S autoantibodies in pregnancy loss
- 11 January 2022
- Published by Elsevier in Journal of Reproductive Immunology
- Vol. 150, 103476
The role of epidermal growth factor-like domain-related abnormalities, protein S Tokushima, and anti-protein S autoantibodies in pregnancy loss
- Open Access
- 1 January 2021
- Published by SAGE Publications in Clinical and Applied Thrombosis/Hemostasis
- Vol. 27
Reduced Activity of Protein S in Plasma: A Risk Factor for Venous Thromboembolism in the Japanese Population
The quantitative assay of protein S can help in rapidly identifying carriers of abnormal protein S molecules through a simple procedure (by determining the total protein S mass, total protein S activity, and protein S-specific activity in blood), without genetic testing. To clarify the relationship between venous thromboembolism (VTE) and protein S-specific activity, and its role in the diagnosis of thrombosis in Japanese persons, the protein S-specific activity was measured and compared between patients with thrombosis and healthy individuals. The protein S-specific activity of each participant was calculated from the ratio of total protein S activity to total protein S antigen level. Plasma samples were collected from 133 healthy individuals, 57 patients with venous thrombosis, 118 patients with arterial thrombosis, and 185 non-thrombotic patients. The protein S-specific activity of one-third of the patients with VTE was below the line of Y = 0.85X (−2 S.D.). Most protein S activities in the plasma of non-thrombotic patients were near the Y = X line, as observed in healthy individuals. In conclusion, it was clearly shown that monitoring protein S activity and protein S-specific activity in blood is useful for predicting the onset and preventing venous thrombosis in at least the Japanese population.
- 1 January 2021
- Published by SAGE Publications in Clinical and Applied Thrombosis/Hemostasis
- Vol. 27
Open AccessReduced Activity of Protein S in Plasma: A Risk Factor for Venous Thromboembolism in the Japanese Population
The quantitative assay of protein S can help in rapidly identifying carriers of abnormal protein S molecules through a simple procedure (by determining the total protein S mass, total protein S activity, and protein S-specific activity in blood), without genetic testing. To clarify the relationship between venous thromboembolism (VTE) and protein S-specific activity, and its role in the diagnosis of thrombosis in Japanese persons, the protein S-specific activity was measured and compared between patients with thrombosis and healthy individuals. The protein S-specific activity of each participant was calculated from the ratio of total protein S activity to total protein S antigen level. Plasma samples were collected from 133 healthy individuals, 57 patients with venous thrombosis, 118 patients with arterial thrombosis, and 185 non-thrombotic patients. The protein S-specific activity of one-third of the patients with VTE was below the line of Y = 0.85X (−2 S.D.). Most protein S activities in the plasma of non-thrombotic patients were near the Y = X line, as observed in healthy individuals. In conclusion, it was clearly shown that monitoring protein S activity and protein S-specific activity in blood is useful for predicting the onset and preventing venous thrombosis in at least the Japanese population.
- 1 August 2018
- Published by Elsevier in Thrombosis Research
- Vol. 168, 60-62
Protein S-specific activity assay system is not affected by direct oral anticoagulants
- 1 August 2018
- Published by Elsevier in Thrombosis Research
- Vol. 168, 60-62
Protein S-specific activity assay system is not affected by direct oral anticoagulants
- Open Access
- 1 January 2013
- Published by Annals of Laboratory Medicine in Annals of Laboratory Medicine
- Vol. 33 (1) , 8-13
Activated Protein C Anticoagulant System Dysfunction and Thrombophilia in Asia
Thrombophilia that is common among Caucasians is caused by genetic polymorphisms of coagulation factor V Leiden (R506Q) and prothrombin G20210A. Unlike that in Caucasians, thrombophilia that is common in the Japanese and Chinese involve dysfunction of the activated protein C (APC) anticoagulant system caused by abnormal protein S and protein C molecules. Approximately 50% of Japanese and Chinese individuals who develop venous thrombosis have reduced activities of protein S. The abnormal sites causing the protein S molecule abnormalities are distributed throughout the protein S gene, PROS1. One of the most common abnormalities is protein S Tokushima (K155E), which accounts for about 30% of the protein S molecule abnormalities in the Japanese. Whether APC dysfunction occurs in other Asian countries is an important aspect of mapping thrombophilia among Asians. International surveys using an accurate assay system are needed to determine this.
- 1 January 2013
- Published by Annals of Laboratory Medicine in Annals of Laboratory Medicine
- Vol. 33 (1) , 8-13
Open AccessActivated Protein C Anticoagulant System Dysfunction and Thrombophilia in Asia
Thrombophilia that is common among Caucasians is caused by genetic polymorphisms of coagulation factor V Leiden (R506Q) and prothrombin G20210A. Unlike that in Caucasians, thrombophilia that is common in the Japanese and Chinese involve dysfunction of the activated protein C (APC) anticoagulant system caused by abnormal protein S and protein C molecules. Approximately 50% of Japanese and Chinese individuals who develop venous thrombosis have reduced activities of protein S. The abnormal sites causing the protein S molecule abnormalities are distributed throughout the protein S gene, PROS1. One of the most common abnormalities is protein S Tokushima (K155E), which accounts for about 30% of the protein S molecule abnormalities in the Japanese. Whether APC dysfunction occurs in other Asian countries is an important aspect of mapping thrombophilia among Asians. International surveys using an accurate assay system are needed to determine this.
- 7 July 2010
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 48 (9) , 1263-1269
Liquid phase immunoassays utilizing magnetic markers and SQUID magnetometer
Background: Immunoassays are one main detection system used in the field of clinical chemistry. Recent developments of a new detection method utilizing a magnetic marker and magnetic sensor have enabled rapid and sensitive immunoassay without the need for bound/free (BF) separation. Methods: Newly-synthesized conjugated avidin was used as the magnetic marker for quantitative analysis of human interleukin-8 (hIL-8) and immunoglobulin E (hIgE) in several media. A superconducting quantum interference device sensor detected the magnetic fields from markers fixed to antigens by the sandwich method. Magnetic signals from unbound markers were nearly zero due to Brownian rotation. Results: Our magnetic immunoassay could detect four attomoles of model proteins (hIL-8, hIgE) in phosphate buffer without BF separation. Using our standard curve, the range of protein detected ranged from 40 femtomoles to 4 attomoles, and we observed a strong association between protein amounts and magnetic signals from the bound markers. The homogeneous immunoassay could also quantify three hundred cells from the fungus Candida albicans in phosphate buffer. Conclusions: The present study demonstrates the ability of magnetic markers for measuring biological targets without BF separation. This detection system has great potential for use as the next generation's analytical system. Clin Chem Lab Med 2010;48:1263–9.
- 7 July 2010
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 48 (9) , 1263-1269
Liquid phase immunoassays utilizing magnetic markers and SQUID magnetometer
Background: Immunoassays are one main detection system used in the field of clinical chemistry. Recent developments of a new detection method utilizing a magnetic marker and magnetic sensor have enabled rapid and sensitive immunoassay without the need for bound/free (BF) separation. Methods: Newly-synthesized conjugated avidin was used as the magnetic marker for quantitative analysis of human interleukin-8 (hIL-8) and immunoglobulin E (hIgE) in several media. A superconducting quantum interference device sensor detected the magnetic fields from markers fixed to antigens by the sandwich method. Magnetic signals from unbound markers were nearly zero due to Brownian rotation. Results: Our magnetic immunoassay could detect four attomoles of model proteins (hIL-8, hIgE) in phosphate buffer without BF separation. Using our standard curve, the range of protein detected ranged from 40 femtomoles to 4 attomoles, and we observed a strong association between protein amounts and magnetic signals from the bound markers. The homogeneous immunoassay could also quantify three hundred cells from the fungus Candida albicans in phosphate buffer. Conclusions: The present study demonstrates the ability of magnetic markers for measuring biological targets without BF separation. This detection system has great potential for use as the next generation's analytical system. Clin Chem Lab Med 2010;48:1263–9.
- 29 May 2007
- Published by Elsevier in Physica C: Superconductivity and its Applications
- Vol. 463-465, 1024-1028
Reduction of the magnetic signal from unbound magnetic markers for magnetic immunoassay without bound/free separation
- 29 May 2007
- Published by Elsevier in Physica C: Superconductivity and its Applications
- Vol. 463-465, 1024-1028
Reduction of the magnetic signal from unbound magnetic markers for magnetic immunoassay without bound/free separation
- 1 April 2007
- Vol. 55 (4) , 351-7
[Development of liquid phase immunoassay system using magnetic nanoparticles].
Biological immunoassay is a major detection system of biological materials from patient samples. Our group has been developing a highly sensitive immunoassay system using magnetic nanoparticles made from Fe3O4. Since unbound magnetic markers randomly move in solvent due to Brownian motion, there is no magnetic signal from unbound magnetic markers; therefore, the separation of bound from unbound markers (B/F separation) is not required. This advantage means that the detection time is greatly decreased in comparison with a normal method using fluorescent/enzyme reagent. In this paper, we describe the configuration of the developed system and demonstrate the performance of the detection of magnetic nanoparticles.
- 1 April 2007
- Vol. 55 (4) , 351-7
[Development of liquid phase immunoassay system using magnetic nanoparticles].
Biological immunoassay is a major detection system of biological materials from patient samples. Our group has been developing a highly sensitive immunoassay system using magnetic nanoparticles made from Fe3O4. Since unbound magnetic markers randomly move in solvent due to Brownian motion, there is no magnetic signal from unbound magnetic markers; therefore, the separation of bound from unbound markers (B/F separation) is not required. This advantage means that the detection time is greatly decreased in comparison with a normal method using fluorescent/enzyme reagent. In this paper, we describe the configuration of the developed system and demonstrate the performance of the detection of magnetic nanoparticles.
- 1 February 2005
- Published by Institute of Electronics, Information and Communications Engineers (IEICE) in IEICE Transactions on Electronics
- Vol. E88-C (2) , 158-167
Magnetic Marker and High Tc Superconducting Quantum Interference Device for Biological Immunoassays
- 1 February 2005
- Published by Institute of Electronics, Information and Communications Engineers (IEICE) in IEICE Transactions on Electronics
- Vol. E88-C (2) , 158-167
Magnetic Marker and High Tc Superconducting Quantum Interference Device for Biological Immunoassays